Comparision of two invasive test of prostate in patient with high prostate specific antigen.

Prospective study of trucut biopsy vs fine needle aspiration cytology of prostate in patient with prostate specific antigen 4 ng/ml

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/05/019240

Enrollment

Registered

2019-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms Health Condition 2: N400- Benign prostatic hyperplasia without lower urinary tract symptoms Health Condition 3: C61- Malignant neoplasm of prostate Health Condition 4: N403- Nodular prostate with lower urinary tract symptoms Health Condition 5: N402- Nodular prostate without lower urinary tract symptoms

Interventions

Intervention1: Analysis of Prostate Specific Agent and Trucut biopsy of prostate and FNAC: cOMPARING BETWEEN THE SENSITIVITY AND SPECIFICITY OF TRUCUT BIOPSY AND fnac OF prostate in PSA 4ng/ml Control

Eligibility

Inclusion criteria

Inclusion criteria: Cases with serum PSA >4 ng /dl

Exclusion criteria

Exclusion criteria: Patient not willing to give consent Cases with serum PSA Bleeding disorder

Design outcomes

Primary

Measure	Time frame
To analyse the sensitivity and specificity of diagnostic FNAC and Trucut biopsy in various disorders of prostateTimepoint: 15 days	—

Secondary

Measure	Time frame
To find an effective screening modality for prostate cancer. To effectively diagnose prostate disorders with minimal interventionTimepoint: 2years	—

Countries

India

Contacts

Public ContactDr Sarav S Bamania

Govt. Medical college Bhavanagar

somanirajan@yahoo.in9825572796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026